Navigation Links
SGX - Lilly Merger Offer Receives Positive Opinions From Proxy Advisory Firms
Date:8/13/2008

SAN DIEGO, Aug. 13 /PRNewswire-FirstCall/ -- SGX Pharmaceuticals, Inc. (Nasdaq: SGXP) today announced that Glass Lewis & Co. and Institutional Shareholder Services (ISS), two leading proxy advisory firms, have recommended that SGX stockholders vote "FOR" the merger agreement with Eli Lilly and Company (NYSE: LLY) at the SGX Special Stockholders Meeting scheduled at 9 am California Time for August 20, 2008.

The Board of Directors of SGX unanimously recommends that the SGX stockholders vote "FOR" the approval and adoption of the agreement and plan of merger and the approval of the merger and related transactions as described in the definitive proxy statement that SGX filed on July 21, 2008.

SGX encourages all stockholders to vote their shares and to contact Georgeson Inc., SGX's proxy solicitation firm, toll tree at 877-278-6774 if they have any questions or need any assistance in voting their shares.

In addition, the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 applicable to the proposed merger expired on August 11, 2008.

The completion of the proposed merger continues to be subject to the satisfaction or waiver of a number of closing conditions, including, among others, (1) adoption of the agreement and plan of merger ("Merger Agreement") by the holders of a majority of SGX's outstanding common stock, (2) subject to certain exceptions, the absence of any material adverse effect on SGX from and after the date of the Merger Agreement, (3) the absence of any leg
'/>"/>

SOURCE SGX Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Emisphere Technologies, Inc. and Eli Lilly and Company Settle Ongoing Litigation
2. Lilly Declares Fourth-Quarter Dividend
3. Robert Conley, M.D. to Join Lilly; Will assume a neuroscience leadership role as a Distinguished Lilly Scholar
4. Lilly and BioMS Medical Announce Global Licensing and Development Agreement
5. Daiichi Sankyo, Lilly Submit New Drug Application for Investigational Antiplatelet Drug, Prasugrel, with U.S. Food and Drug Administration
6. In response to a New England Journal of Medicine article published yesterday and subsequent media coverage, Eli Lilly and Company issued the following statement:
7. Lilly Announces Termination of AIR Insulin Program
8. HistoRx and Lilly Extend, Expand AQUA(R) Analysis Partnership
9. Pelikan Technologies and Lilly Form Alliance to Promote Diabetes Education
10. Lilly Reports Solid First-Quarter Results
11. Lilly CEO Praises Massachusetts Leadership in Biotech, Urges Policy Prescriptions to Help Ensure States Investment Generates Dividends and Jobs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/26/2014)... MINNEAPOLIS and REHOVOT, Israel , ... UK medical 3D printing specialist, Replica 3DM, supports NHS hospitals ... 3D Printers   - Performing surgery ... and anesthetic times; improves patient recovery and provides an effective ... Stratasys Ltd. (Nasdaq: SSYS ), a ...
(Date:8/26/2014)... , Aug. 26, 2014 Technology ... the symbol (NUUU) has two (2) wholly- owned ... two subsidiaries harness scientifically advanced technology to provide ... NUUU,s Renuell Int,l, Inc. is launching ... skin care products that is made possible because ...
(Date:8/26/2014)... -- Trovagene, Inc. (NASDAQ:  TROV) presented data at ... to the Clinic with an oral presentation ... Tumor DNA in Urine." In this presentation Trovagene ... Monitoring (PCM) platform and results from several studies ... tumor DNA mutations from urine samples of cancer ...
(Date:8/26/2014)... 26, 2014 Albany Molecular Research Inc. (NASDAQ: ... S. Marth , President and Chief Executive Officer at ... Conference on Monday, September 8, 2014 at 8:45 a.m. ... the presentation can be accessed at AMRI,s Investor Relations ... webcast will be archived for 90 days following the ...
Breaking Biology Technology:Twelve UK Hospitals Enjoy Reduced Surgical Procedure Times and Decline in Costs by Implementing Stratasys 3D Printing Solutions 2Twelve UK Hospitals Enjoy Reduced Surgical Procedure Times and Decline in Costs by Implementing Stratasys 3D Printing Solutions 3Twelve UK Hospitals Enjoy Reduced Surgical Procedure Times and Decline in Costs by Implementing Stratasys 3D Printing Solutions 4Twelve UK Hospitals Enjoy Reduced Surgical Procedure Times and Decline in Costs by Implementing Stratasys 3D Printing Solutions 5Technology Applications International Corporation, Trading Symbol NUUU now trading on NASDAQ's Over the Counter Bulletin Board (OTC BB) 2Highly Sensitive and Quantitative Analytical Performance is Translational for Clinical Utility of Cell-Free Tumor DNA Diagnostics 2Highly Sensitive and Quantitative Analytical Performance is Translational for Clinical Utility of Cell-Free Tumor DNA Diagnostics 3Highly Sensitive and Quantitative Analytical Performance is Translational for Clinical Utility of Cell-Free Tumor DNA Diagnostics 4
... CALGARY, April 16 /PRNewswire-FirstCall/ - Oncolytics Biotech Inc.,("Oncolytics") ... his research group at St. James,s University Hospital ... in the April 10 online issue of,Gene Therapy. ... by,Oncolytic Reovirus for the Treatment of Melanoma.", ...
... Technology (NIST), in collaboration with the National Aeronautics ... for making essential measurements on samples of single-walled ... current best practices for characterizing one of the ... generation of nanoscale materials. , The nanotubes are ...
... Inc. (Nasdaq: VION ) today announced that it ... The Nasdaq Capital Market,listing requirements, including the time frame ... announced that it had received a letter, dated,March 24, ... Company,that it does not comply with Marketplace Rule 4310(c ...
Cached Biology Technology:Oncolytics Biotech Inc. Announces Gene Therapy Publication on Reovirus Treatment for Melanoma 2Carbon nanotube measurements: latest in NIST 'how-to' series 2Vion Pharmaceuticals Files Plan With Nasdaq 2Vion Pharmaceuticals Files Plan With Nasdaq 3
(Date:8/26/2014)... have provided the first evidence that the lack ... early signs of dementia. , Published in ... absence of the protein MK2/3 promotes structural and ... These changes were shown to have a significant ... learning and memory formation capabilities. , An absence ...
(Date:8/26/2014)... consumers, and suppliers has prompted manufacturers to set ... they emit from their smokestacks or discharge into ... environmental performance at every step in their process, ... use and recycling of their products. , This ... as life cycle engineering, which connects the engineers ...
(Date:8/26/2014)... University of Illinois engineers are bringing a ... researchers developed a new continuous glucose monitoring material ... the wavelength shift is so precise that doctors ... for automatic insulin dosing - something not ... , "There are significant limitations to current continuous ...
Breaking Biology News(10 mins):Lack of naturally occuring protein linked to dementia 2Yale journal explores advances in sustainable manufacturing 2A glucose meter of a different color provides continuous monitoring 2A glucose meter of a different color provides continuous monitoring 3
... therapies often succeed at initially eliminating the bulk ... but are eventually thwarted because they cannot eliminate ... cancer stem cells, which ultimately become the source ... by scientists at the University of Pittsburgh School ...
... New research from Colorado State University shows that the ... circadian -- or daily -- rhythms. The study, publishing ... current theory that only 10 percent to 15 percent ... scientists have long known that circadian rhythms regulate the ...
... temples and cultivated for its wood and cottony fibers, ... biologists have clung to for decades: the notion that ... continents were connected 96 million years ago. , Research ... colleagues shows that kapok---and perhaps other rainforest--trees colonized Africa ...
Cached Biology News:Cancer stem cells similar to normal stem cells can thwart anti-cancer agents 2Research finds that circadian rhythms dominate all life functions 2Research finds that circadian rhythms dominate all life functions 3The kapok connection -- Study explains rainforest similarities 2
Anti-Human IFN-Gamma Receptor Chain 2 (beta chain) [CD119], Rabbit serum, NON-neutralizing polyclonal antibody...
AANAT [Arylalkylamine N-acetyltransferase; EC 2.3.1.87]...
Rac1/2/3 (L129) Antibody Shipping Temperature: HOT Storage Temperature: -20C...
Sheep polyclonal to EBNA 3B ( Abpromise for all tested applications). Antigen: Full length protein....
Biology Products: